(Q35283386)

7 August 2017

0 references

1 reference

title

Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis (English)

1 reference

7 August 2017

1 reference

1 reference

Philippe Gabriel Steg

6

object named as

Philippe Gabriel Steg

0 references

Sammy Elmariah

object named as

Sammy Elmariah

1

0 references

Dean J Kereiakes

7

object named as

Dean J Kereiakes

1 reference

7 August 2017

2

Laura Mauri

1 reference

7 August 2017

3

Gheorghe Doros

2 references

ORCID Public Data File 2021

7 August 2017

Benjamin Z Galper

4

1 reference

7 August 2017

Kelly E O'Neill

5

1 reference

7 August 2017

Robert W Yeh

8

1 reference

7 August 2017

language of work or name

English

0 references

publication date

16 November 2014

1 reference

7 August 2017

1 reference

7 August 2017

385

1 reference

7 August 2017

9970

1 reference

7 August 2017

792-798

1 reference

Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents

7 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386690

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386690

Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386690

Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386690

Effects of clopidogrel added to aspirin in patients with recent lacunar stroke

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386690

Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386690

Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386690

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386690

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386690

Effect of clopidogrel added to aspirin in patients with atrial fibrillation

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386690

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386690

Measuring inconsistency in meta-analyses

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386690

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386690

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386690

Bayesian methods in health technology assessment: a review

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386690

Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386690

Death (after percutaneous coronary intervention) is no longer what it used to be.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386690

Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386690

The BUGS project: Evolution, critique and future directions

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386690

Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386690

Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386690

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386690

Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial

26 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962052-3

inferred from DOI database lookup

7 January 2021

based on heuristic

A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962052-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Trends in cause of death after percutaneous coronary intervention

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962052-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0140-6736(14)62052-3

1 reference

7 August 2017

1 reference

7 August 2017

1 reference